Why Public Interest in Mitochondrial Function Testing is Growing

Today, more ordinary people are taking an interest in tracking their mitochondrial health in order to take concrete steps to improve their overall wellness and boost longevity. Previously, such interest was a mainstay among elite athletes, scientists and biohacking enthusiasts. Why are more people choosing to have their mitochondrial health tested? 

For starters, mitochondria are powerhouses inside body cells. These organelles play several vital roles, such as generating energy for cellular use, participating in the immune system’s response to pathogens, contributing to cell signaling, and playing a role in programmed cell death (aka apoptosis). Mitochondrial health is therefore essential to our health and body functioning. 

As more scientific data has become available about how important mitochondria are, the public has picked interest in learning about these structures. For instance, studies have linked mitochondrial dysfunction to accelerated aging and neurodegenerative diseases like Parkinson’s disease and Alzheimer’s. 

Other medical conditions, such as chronic fatigue, brain fog, muscle weakness and memory decline have since been linked to malfunctions in the mitochondria. Many people struggle with these conditions, and learning about their link to mitochondrial health has created a need to track this important biometric. 

Easy access to information via the internet has made public awareness about mitochondrial health spread rapidly. When people access information, the next logical step is learning how to make use of that information. 

Advances in biomedical technology in the recent past now mean that mitochondrial health tests are no longer the preserve of clinical study labs. Many companies, such as InsideTracker, Tally Health and Novos Labs have commercialized affordable mitochondrial health tests that people can undergo in order to assess how well their mitochondria are functioning. 

Fortunately, some interventions, such as having a balanced diet, exercising more, tweaking your supplements regimen and managing stress, to boost metabolic health are measures that ordinary people can incorporate into their routines. When helpful steps are seen as actionable, more people are likely to be motivated to have the tests done to establish how quickly they are aging at the biological/cellular level and take steps to boost their wellbeing. 

For those who have been diagnosed with progressive medical conditions arising from dysfunctional mitochondria, there is hope. Recent research is uncovering ways to edit mitochondrial DNA in order to restore mitochondrial function. Furthermore, biomedical R&D programs by companies like Clene Inc. (NASDAQ: CLNN) and other entities are showing progress in developing different solutions geared at restoring mitochondrial health among individuals afflicted by ailments like Parkinson’s disease, Alzheimer’s and other neurological conditions. 

NOTE TO INVESTORS: The latest news and updates relating to Clene Inc. (NASDAQ: CLNN) are available in the company’s newsroom at https://ibn.fm/CLNN 

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN